Goblin House
Claim investigated: The absence of USASpending contract records suggests NSO Group has not received direct U.S. federal government contracts, which is notable given the company was placed on the U.S. Commerce Department's Entity List in November 2021 Entity: NSO Group Original confidence: inferential Result: STRENGTHENED → SECONDARY
The inference appears sound but is built on fundamentally compromised source data. While the absence of USASpending records is consistent with Entity List sanctions preventing direct federal contracts, the underlying SEC filing data contains critical integrity issues (future dates, missing accession numbers) that undermine confidence in the broader analysis.
Reasoning: The USASpending absence can be independently verified and aligns with expected outcomes from November 2021 Entity List designation, which legally prohibits most U.S. government business with NSO Group. However, the conclusion is strengthened by regulatory logic rather than the compromised source data.
USASpending: Q Cyber Technologies, OSY Technologies, WestBridge Technologies (known NSO subsidiaries)
Would reveal if NSO Group used subsidiary structures to obtain U.S. federal contracts before Entity List designation
court records: NSO Group Technologies AND (contract OR procurement OR federal government)
Contract disputes or litigation could reveal undisclosed government relationships
FEC: NSO Group, Q Cyber Technologies, Shalev Hulio, Omri Lavie
Political contributions by NSO executives could indicate influence operations parallel to contracting efforts
LDA: Israel AND surveillance AND (Pegasus OR spyware)
Would reveal if other entities lobbied on NSO Group's behalf or on related surveillance policy issues
other: State procurement databases: NSO Group, Cellebrite, surveillance technology
State/local contracts would not appear in federal USASpending database but could represent significant market presence
SIGNIFICANT — Confirms that Entity List sanctions effectively severed NSO Group's direct federal contracting pathways, but raises questions about pre-2021 relationships and ongoing state/local market access that could circumvent federal restrictions.